Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001179110-19-011012

Options or other derivatives

  • Chief Financial Officer acquired 25,813 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pizzie Nick Chief Financial Officer 2019-10-10 Grant or award · Employee Stock Option (right to buy) +25,813 25,813 D
Loading xslF345X03/edgar.xml…